Search research articles
Contact Us
Filters
Showing results (231-240 of 254) with videos related to
Page
of 26
Sort By:
American Journal of Human Genetics
|
September 9, 2017
RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes
Margot R F Reijnders, Nurhuda M Ansor, Maria Kousi, et al.
Journal of Medicinal Chemistry
|
November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2)
Eddy W Yue, C Anne Higley, Susan V DiMeo, et al.
Journal of Medicinal Chemistry
|
June 23, 2006
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic
Andrew P Combs, Wenyu Zhu, Matthew L Crawley, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
Eddy W Yue, Richard Sparks, Padmaja Polam, et al.
Molecular Psychiatry
|
December 7, 2016
Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population
H Yu, H Yan, J Li, et al.
Journal of Medicinal Chemistry
|
June 26, 2009
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists
Richard A Hartz, Vijay T Ahuja, Maria Rafalski, et al.
Structure (London, England : 1993)
|
June 25, 2013
Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations
D Sean Froese, Farhad Forouhar, Timothy H Tran, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
Eddy W Yue, Yun-Long Li, Brent Douty, et al.
Journal of Medicinal Chemistry
|
October 14, 2005
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics
Andrew P Combs, Eddy W Yue, Michael Bower, et al.
American Journal of Human Genetics
|
January 15, 2013
LRIG2 mutations cause urofacial syndrome
Helen M Stuart, Neil A Roberts, Berk Burgu, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 254) with videos related to
Sort By:
Page
of 26
American Journal of Human Genetics
|
September 9, 2017
RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes
Margot R F Reijnders, Nurhuda M Ansor, Maria Kousi, et al.
Journal of Medicinal Chemistry
|
November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2)
Eddy W Yue, C Anne Higley, Susan V DiMeo, et al.
Journal of Medicinal Chemistry
|
June 23, 2006
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic
Andrew P Combs, Wenyu Zhu, Matthew L Crawley, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
Eddy W Yue, Richard Sparks, Padmaja Polam, et al.
Molecular Psychiatry
|
December 7, 2016
Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population
H Yu, H Yan, J Li, et al.
Journal of Medicinal Chemistry
|
June 26, 2009
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists
Richard A Hartz, Vijay T Ahuja, Maria Rafalski, et al.
Structure (London, England : 1993)
|
June 25, 2013
Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations
D Sean Froese, Farhad Forouhar, Timothy H Tran, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
Eddy W Yue, Yun-Long Li, Brent Douty, et al.
Journal of Medicinal Chemistry
|
October 14, 2005
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics
Andrew P Combs, Eddy W Yue, Michael Bower, et al.
American Journal of Human Genetics
|
January 15, 2013
LRIG2 mutations cause urofacial syndrome
Helen M Stuart, Neil A Roberts, Berk Burgu, et al.
Page
of 26